Cookson Peirce & Co’s iShares Biotechnology ETF IBB Stock Holding History

Cookson Peirce & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$393K	Sell	2,066 -275	-12%	-$47.3K	0.01%	274
2026 Q1	$395K	Buy	+2,341	New	+$400K	0.02%	249
2025 Q1	–	Sell	-1,882	Closed	-$249K	–	288
2024 Q4	$249K	Hold	1,882	–	–	0.01%	247
2024 Q3	$274K	Hold	1,882	–	–	0.01%	228
2024 Q2	$258K	Hold	1,882	–	–	0.01%	214
2024 Q1	$258K	Hold	1,882	–	–	0.01%	204
2023 Q4	$256K	Hold	1,882	–	–	0.02%	185
2023 Q3	$230K	Hold	1,882	–	–	0.02%	189
2023 Q2	$239K	Hold	1,882	–	–	0.01%	191
2023 Q1	$243K	Hold	1,882	–	–	0.02%	186
2022 Q4	$247K	Hold	1,882	–	–	0.02%	175
2022 Q3	$220K	Hold	1,882	–	–	0.02%	169
2022 Q2	$221K	Hold	1,882	–	–	0.02%	176
2022 Q1	$245K	Hold	1,882	–	–	0.01%	188
2021 Q4	$287K	Hold	1,882	–	–	0.02%	183
2021 Q3	$304K	Hold	1,882	–	–	0.02%	172
2021 Q2	$308K	Hold	1,882	–	–	0.02%	178
2021 Q1	$283K	Buy	+1,882	New	+$299K	0.02%	149
2020 Q4	–	Sell	-2,418	Closed	-$327K	–	173
2020 Q3	$327K	Buy	2,418 +60	+3%	+$8.14K	0.02%	120
2020 Q2	$322K	Sell	2,358 -292	-11%	-$37.2K	0.03%	118
2020 Q1	$286K	Buy	+2,650	New	+$305K	0.03%	118

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Cookson Peirce & Co's IBB Position: Q2 2026 in Review

Cookson Peirce & Co reduced its iShares Biotechnology ETF (IBB) stake by 12% in Q2 2026, selling an estimated $47.3K and leaving 2,066 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #274.

Cookson Peirce & Co first reported a position in IBB in Q1 2020 and has held it in 21 quarters since. The position peaked at $395K in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Cookson Peirce & Co held 2,066 shares of iShares Biotechnology ETF worth $393K as of Q2 2026.
Cookson Peirce & Co sold 275 iShares Biotechnology ETF shares in Q2 2026, an estimated $47.3K.
iShares Biotechnology ETF made up 0.01% of Cookson Peirce & Co's portfolio in Q2 2026, its #274 holding.
Cookson Peirce & Co first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 21 quarters since.
Cookson Peirce & Co's iShares Biotechnology ETF position peaked at $395K in Q1 2026.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.